Table 5 Frequency of resource usage in the ≥30 days survivors (n=669)
Hospitalization – No (%) | 669 | (100%) |
Ambulatory care | 644 | (89.5%) |
Anti-thrombotic drugs | 516 | (77.1%) |
Anti-hypertension drugs | 531 | (79.4%) |
Anti-diabetes drugs | 100 | (14.9%) |
Lipid-lowering drugs | 165 | (24.7%) |